What Is Pterostilbene?

Reviewed by SOMA HEALTH's Medical Research Team

Pterostilbene is a naturally occurring stilbene found in blueberries and grapes, chemically close to resveratrol but structurally tuned for better absorption. It has become a fixture in longevity-minded supplement stacks, often marketed as the ‘more bioavailable resveratrol.’ Here is a calm look at what pterostilbene actually is, how it differs from resveratrol, what human research has and has not shown, and where it fits alongside mitochondrial compounds like urolithin A.

What pterostilbene is, at a molecular level

Pterostilbene belongs to a family of plant compounds called stilbenes, which plants produce as part of their defense response. It is most concentrated in blueberries, and also appears in grapes and the heartwood of certain sandalwood-family trees. Structurally, pterostilbene is a close relative of resveratrol: the difference is that two of resveratrol’s hydroxyl (–OH) groups are replaced by methoxy (–OCH₃) groups. This is why pterostilbene is sometimes described as a ‘dimethylated’ analog of resveratrol.

That small chemical change has meaningful consequences. The methoxy groups make the molecule more lipophilic (fat-soluble), which helps it cross cell membranes more readily, and they reduce the number of sites where the body attaches sugar groups during metabolism. Resveratrol is famously difficult to keep in circulation: it is absorbed but then rapidly conjugated and cleared, so blood levels of the intact molecule stay low. Pterostilbene resists that first-pass metabolism better, which is the entire basis of its ‘bioavailability’ reputation.

Pterostilbene vs resveratrol: the bioavailability story

In preclinical pharmacokinetic work in rodents, pterostilbene showed substantially higher oral bioavailability than resveratrol and a longer half-life, largely because it is metabolized more slowly. Resveratrol, by contrast, is often cited as having very low systemic bioavailability in humans because so little of the parent compound survives metabolism. So the headline – that gram-for-gram, more pterostilbene reaches your bloodstream intact – is reasonably grounded.

There are two honest caveats. First, ‘more bioavailable’ is not the same as ‘more effective for a given outcome’; higher blood levels only matter if the downstream biology delivers. Second, most direct head-to-head bioavailability comparisons come from animal and cell studies, not large human trials. It is fair to say pterostilbene is the more absorbable molecule, and unfair to claim that settles which compound is ‘better’ for any particular goal.

What human research actually shows

Human data on pterostilbene is limited but not absent. The most cited work comes from a University of Mississippi research group that ran a randomized, double-blind, placebo-controlled trial (Riche and colleagues) in adults with elevated cholesterol. Over several weeks, pterostilbene was associated with reductions in blood pressure at the doses studied. A separate safety analysis from the same trial program reported that pterostilbene was generally well tolerated.

Crucially, the same research surfaced an honest limitation: at the higher dose, and in participants not also taking a lipid-lowering medication, pterostilbene was associated with an increase in LDL cholesterol. That is exactly the kind of nuance a careful reader should hold onto – a compound can move one marker in a welcome direction while nudging another the wrong way. It is a reminder that ‘natural’ and ‘longevity-branded’ do not mean ‘consequence-free.’ None of this is a basis for treating high blood pressure or cholesterol; those are medical conditions that belong with your physician.

Proposed mechanisms – and how much is still preclinical

Most of pterostilbene’s proposed biology comes from laboratory and animal models rather than human trials, and it deserves that label. In cell and rodent studies, pterostilbene has been explored as an antioxidant, as a modulator of sirtuin (SIRT1) signaling, and as an influence on AMPK and other metabolic pathways involved in how cells sense energy. Early preclinical research is also exploring effects on cognition and metabolic markers.

The gap between ‘interesting in a dish’ and ‘proven in people’ is wide, and pterostilbene sits mostly on the early side of it. The systematic reviews that cover stilbenes generally conclude that the human longevity evidence is still emerging – a caution that applies broadly across this ingredient category.

Where urolithin A fits – a complementary, better-mapped pathway

People researching pterostilbene are usually chasing a broader goal: aging well at the cellular level. Urolithin A approaches that goal through a distinct, well-characterized mechanism called mitophagy – the process by which cells identify and recycle worn-out mitochondria so fresher, better-functioning ones can take their place. Urolithin A is a gut postbiotic: your microbiome makes it from ellagitannins in foods like pomegranate, walnuts, and berries, but only some people carry the microbes that convert it efficiently, which is a large part of why it is taken as a supplement.

Importantly, urolithin A carries a more developed human evidence base than most stilbenes. In humans, Andreux and colleagues (2019, Nature Metabolism) reported the first-in-human study, finding urolithin A safe and well tolerated up to 1,000 mg per day and showing a mitochondrial gene-expression signature. Later randomized human trials – Liu and D’Amico (2022, JAMA Network Open) in older adults over roughly four months, and Singh and colleagues (2022, Cell Reports Medicine) in middle-aged adults using 500 mg and 1,000 mg arms – explored muscle endurance, strength, and exercise performance. A 2025 randomized trial in Nature Aging reported support for immune-cell mitochondrial health in midlife adults. The foundational mitophagy and lifespan findings (Ryu and colleagues, 2016, Nature Medicine) are preclinical, established in C. elegans and rodents, and should be read as such. If you want the full picture, our complete urolithin A guide and our roundup of the best urolithin A gummies lay it out, and our mitochondrial health primer and explainer on what mitophagy is go deeper on the underlying biology.

Practical guidance if you are considering pterostilbene

Pterostilbene supplements are widely sold, typically in the low-hundreds-of-milligrams range, though products vary – check the current label for exact amounts. Because human data is thin and one trial signaled an LDL change at a higher dose, it is sensible to start conservatively, avoid stacking multiple stilbenes without a reason, and monitor rather than assume. If you take medications, have a cardiovascular or metabolic condition, or are pregnant or nursing, talk to a qualified healthcare provider before starting – this is education, not a treatment recommendation, and pterostilbene is not a therapy for any condition.

Whichever compound you explore, the same principle applies: pick one mechanism you actually understand, use a third-party-tested product, and give it enough time to matter rather than rotating through trend ingredients.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.